Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "safety"

1082 News Found

India grants Emergency Use Authorisation to Sputnik Light
News | February 07, 2022

India grants Emergency Use Authorisation to Sputnik Light

This is the ninth Covid-19 vaccine approved in India


Expert panel recommends Emergency Use Authorisation for Sputnik Light
News | February 05, 2022

Expert panel recommends Emergency Use Authorisation for Sputnik Light

The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval


Sputnik V vaccine granted full approval in Russia
News | February 04, 2022

Sputnik V vaccine granted full approval in Russia

Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world


Moderna’s Covid-19 `Spikevax’ vaccine gets full USFDA approval
Biotech | February 01, 2022

Moderna’s Covid-19 `Spikevax’ vaccine gets full USFDA approval

Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel


Budget 22-23: Healthcare sector applauds focus on mental health
News | February 01, 2022

Budget 22-23: Healthcare sector applauds focus on mental health

A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook


Daiichi Sankyo commences trial for booster mRNA vaccine against Covid-19
Biotech | January 31, 2022

Daiichi Sankyo commences trial for booster mRNA vaccine against Covid-19

DS-5670 is an mRNA vaccine against Covid-19 using a novel nucleic acid delivery technology discovered by the company


Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance
Hospitals | January 30, 2022

Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance

Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022


Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate
Biotech | January 29, 2022

Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate

Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China


Moderna working on Omicron-specific booster candidate
News | January 27, 2022

Moderna working on Omicron-specific booster candidate

This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older


USFDA rejects Merck’s gefapixant; gain approval in Japan
News | January 25, 2022

USFDA rejects Merck’s gefapixant; gain approval in Japan

Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant